BMC Cancer · 2021 · 33 citations · 30 references
MedicineOncologyPathologyEndocrine OncologyImmunotherapyMetastasisEndocrine Tumor PrognosisNeuroendocrine TumorsPancreatic CancerPancreatic DiseasesPancreatic PathologyTumor-associated MacrophagesCancer-associated MacrophagesClinicopathologic FeaturesLymph Node Metastasis PrognosisLymphovascular Invasion PrognosisPancreatic Neuroendocrine NeoplasmsPancreatic Resection SpecimensPerineural Invasion AssessmentPerineural Invasion Prognosis
BACKGROUND: Recent studies have suggested the important roles of CD47 and tumor-associated macrophages in the prognosis and immunotherapy of various human malignancies. However, the clinical significance of CD47 expression and CD163+ TAMs in pancreatic neuroendocrine tumor (PanNET) remains unclear. METHODS: In this study, 47 well-differentiated PanNET resection specimens were collected. CD47 expression and CD163+ macrophages were evaluated using immunohistochemistry and correlated with clinicopathologic properties. RESULTS: Positive CD47 staining was seen in all PanNETs as well as adjacent normal islets. Compared to normal islets, CD47 overexpressed in PanNETs (p = 0.0015). In the cohort, lymph node metastasis (LNM), lymphovascular invasion (LVI), and perineural invasion (PNI) were found in 36.2, 59.6, and 48.9% of the cases, respectively. Interestingly, PanNETs with LNM, LVI, or PNI had significantly lower H-score of CD47 than those without LNM (p = 0.035), LVI (p = 0.0005), or PNI (p = 0.0035). PanNETs in patients with disease progression (recurrence/death) also showed a significantly lower expression of CD47 than those without progression (p = 0.022). In contrast, CD163+ macrophage counts were significantly higher in cases with LNM, LVI, and PNI. CONCLUSIONS: Our data suggest relative low CD47 expression and high CD163+ TAMs may act as indicators for poor prognosis of PanNETs.
30
Ravindra Majeti, Mark P. Chao, Ash A. Alizadeh et al. · Cell · 2009 · 1.7K citations
Medicine, Hematology, Oncology +14
Mark P. Chao, Ash A. Alizadeh, Chad Tang et al. · Cell · 2010 · 1.1K citations · Full text
Medicine, Immunology, Oncology +14